News | March 05, 2024
Biocon Biologics secures Canada market entry date for YESAFILI
This agreement paves the way for the introduction of YESAFILI into the Canadian market
This agreement paves the way for the introduction of YESAFILI into the Canadian market
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The observations do not pose any risk to site's compliance standards or its business continuity
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Submission to be reviewed under FDA real-time oncology review and Project Orbis
The company intends to respond to the two minor observations within the stipulated time
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
Subscribe To Our Newsletter & Stay Updated
